Page last updated: 2024-10-31

nocodazole and Huntington Disease

nocodazole has been researched along with Huntington Disease in 2 studies

Huntington Disease: A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Webb, JL1
Ravikumar, B1
Rubinsztein, DC1
Hazeki, N1
Nakamura, K1
Goto, J1
Kanazawa, I1

Other Studies

2 other studies available for nocodazole and Huntington Disease

ArticleYear
Microtubule disruption inhibits autophagosome-lysosome fusion: implications for studying the roles of aggresomes in polyglutamine diseases.
    The international journal of biochemistry & cell biology, 2004, Volume: 36, Issue:12

    Topics: Animals; Autophagy; Chlorocebus aethiops; COS Cells; Humans; Huntington Disease; Inclusion Bodies; L

2004
Rapid aggregate formation of the huntingtin N-terminal fragment carrying an expanded polyglutamine tract.
    Biochemical and biophysical research communications, 1999, Mar-16, Volume: 256, Issue:2

    Topics: Animals; Blotting, Western; Cell Nucleus; COS Cells; Cycloheximide; Cytochalasin D; Cytoplasm; Exons

1999